Alfacell Corporation to Present at C.E. Unterberg, Towbin Emerging
Growth Opportunities Conference
BLOOMFIELD, N.J., July 05, 2007 /PRNewswire/ --
AlfacellCorporation today announced that Lawrence A. Kenyon, executive vicepresident, chief financial officer and corporate secretary, willpresent an overview of the company's product development programsat 8 a.m. EDT on Thursday, July 12, 2007, at the C.E. Unterberg,Towbin Emerging Growth Opportunities Conference in New York. The aud...
In Vitro and In Vivo Data Show Alfacell's Onocanse is Active
Against Naive and Chemoresistant Neuroblastoma Cells
Pre-Clinical Results Demonstrate Potential of ONCONASE forTreatment of Neuroblastoma BLOOMFIELD, N.J., June 27, 2007 /PRNewswire-FirstCall/ --
Alfacell Corporation today announced that new data show ONCONASE,the company's lead drug candidate, is active against naive andchemoresistant neuroblastoma cells. The pre-clinical in vitro and in vivo data published in CancerLetters (2007; Vo...
Preclinical Data Show Alfacell's Onconase Inhibits Tumor Growth of
Non-Small Cell Lung Cancer, Breast Cancer Cells
Poster Presented at AACR Annual Meeting BLOOMFIELD, N.J., April 16, 2007 /PRNewswire-FirstCall/ --
Alfacell Corporation today announced that in vivo and in vitropreclinical data presented in a poster at the American Associationfor Cancer Research (AACR) Annual Meeting show that ONCONASE(ranpirnase) significantly inhibits tumor growth of non-small celllung cancer (NSCLC) and breast cancer c...
Researchers Identify Intracellular Pathway of Alfacell's Onconase
Paper Published in Journal of Cell Science Shows ONCONASE Uptake inCells Differs from other RNases BLOOMFIELD, N.J., April 05, 2007 /PRNewswire-FirstCall/ --
Alfacell Corporation today announced that European researchers haveidentified the pathway that ONCONASE (ranpirnase) follows to entercells. Published in the Journal of Cell Science (2007; 120: 1405-1411),a paper based on studie...
In vivo Study Results Demonstrating Potential of Alfacell's
Onconase for Treatment of Non-Small Cell Lung Cancer Published in
Anticancer Research
BLOOMFIELD, N.J., March 26, 2007 /PRNewswire-FirstCall/ --
Alfacell Corporation today announced that in vivo study resultsdemonstrating the potential of ONCONASE (ranpirnase) for thetreatment of non-small cell lung cancer (NSCLC) were recentlypublished in Anticancer Research (2007; 27: 299- 308). Based on the work of Intae Lee, Ph.D., at the University ofPennsylvania, a paper entitl...
More>>